Literature DB >> 28124230

Study on Lentivirus-Mediated ABCA7 Improves Neurocognitive Function and Related Mechanisms in the C57BL/6 Mouse Model of Alzheimer's Disease.

Mengqian Li1, Yefeng Yuan1, Bo Hu2, Lei Wu3.   

Abstract

ATP-binding cassette transporter A7 (ABCA7) is expressed in the hippocampus and cortex of the brain and was confirmed to be involved in the development of Alzheimer's disease (AD). Previous studies have demonstrated that ABCA7 regulated Aβ production, lipid transport, leading to AD characteristic pathological changes. However, the role and mechanism of ABCA7 in the context of AD needs further research. We augmented the expression of ABCA7 using lentiviral vector carrying ABCA7 gene to investigate the effect of ABCA7 overexpression on AD mice; then, we further explored the underlying mechanism in vitro. In the present study, ABCA7 was expressed successfully in the hippocampus of AD mice through lentiviral vector mediating ABCA7 gene; we showed that ABCA7 overexpression can effectively improve cognitive behavior of AD mice and diminished Aβ production; meanwhile, ABCA7 overexpression significantly relieved the neurotoxicity of Aβ by promoting cell viability and reducing endoplasmic reticulum stress. In conclusion, our findings showed that ABCA7 had obvious anti-Aβ effect and appeared to improve cognitive function of AD mice. Our results provided a new thought and basic scientific data for the clinical treatment of AD.

Entities:  

Keywords:  ATP-binding cassette transporter A7 (ABCA7); Alzheimer’s disease (AD); Endoplasmic reticulum (ER) stress; β-amyloid (Aβ)

Mesh:

Substances:

Year:  2017        PMID: 28124230     DOI: 10.1007/s12031-017-0889-x

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  21 in total

1.  Swedish amyloid precursor protein mutation increases phosphorylation of eIF2alpha in vitro and in vivo.

Authors:  Hye-Sun Kim; Yoori Choi; Ki-Young Shin; Yuyoung Joo; Yong-Kyu Lee; Sang Yong Jung; Yoo-Hun Suh; Joung-Hun Kim
Journal:  J Neurosci Res       Date:  2007-05-15       Impact factor: 4.164

Review 2.  The Benefits of Exercise and Metabolic Interventions for the Prevention and Early Treatment of Alzheimer's Disease.

Authors:  Ewelina Maliszewska-Cyna; Madelaine Lynch; Jonathan Jordan Oore; Paul Michael Nagy; Isabelle Aubert
Journal:  Curr Alzheimer Res       Date:  2017       Impact factor: 3.498

Review 3.  Alzheimer's disease against peptides products of enzymatic cleavage of APP protein. Forming and variety of fibrillating peptides - some aspects.

Authors:  Małgorzata Marszałek
Journal:  Postepy Hig Med Dosw (Online)       Date:  2016-07-07       Impact factor: 0.270

4.  An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.

Authors:  Elisabete Ferreiro; Rosa Resende; Rui Costa; Catarina R Oliveira; Cláudia M F Pereira
Journal:  Neurobiol Dis       Date:  2006-07-17       Impact factor: 5.996

5.  Deletion of Abca7 increases cerebral amyloid-β accumulation in the J20 mouse model of Alzheimer's disease.

Authors:  Woojin S Kim; Hongyun Li; Kalani Ruberu; Sharon Chan; David A Elliott; Jac Kee Low; David Cheng; Tim Karl; Brett Garner
Journal:  J Neurosci       Date:  2013-03-06       Impact factor: 6.167

Review 6.  Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation.

Authors:  Jan Aaseth; Jan Alexander; Geir Bjørklund; Knut Hestad; Petr Dusek; Per M Roos; Urban Alehagen
Journal:  Biometals       Date:  2016-08-16       Impact factor: 2.949

7.  Analysis by a highly sensitive split luciferase assay of the regions involved in APP dimerization and its impact on processing.

Authors:  Marie Decock; Laetitia El Haylani; Serena Stanga; Ilse Dewachter; Jean-Noël Octave; Steven O Smith; Stefan N Constantinescu; Pascal Kienlen-Campard
Journal:  FEBS Open Bio       Date:  2015-09-06       Impact factor: 2.693

8.  ABCA7 p.G215S as potential protective factor for Alzheimer's disease.

Authors:  Celeste Sassi; Michael A Nalls; Perry G Ridge; Jesse R Gibbs; Jinhui Ding; Michelle K Lupton; Claire Troakes; Katie Lunnon; Safa Al-Sarraj; Kristelle S Brown; Christopher Medway; Naomi Clement; Jenny Lord; James Turton; Jose Bras; Maria R Almeida; Henne Holstege; Eva Louwersheimer; Wiesje M van der Flier; Philip Scheltens; John C Van Swieten; Isabel Santana; Catarina Oliveira; Kevin Morgan; John F Powell; John S Kauwe; Carlos Cruchaga; Alison M Goate; Andrew B Singleton; Rita Guerreiro; John Hardy
Journal:  Neurobiol Aging       Date:  2016-04-20       Impact factor: 4.673

9.  ABCA7 Deficiency Accelerates Amyloid-β Generation and Alzheimer's Neuronal Pathology.

Authors:  Nobutaka Sakae; Chia-Chen Liu; Mitsuru Shinohara; Jessica Frisch-Daiello; Li Ma; Yu Yamazaki; Masaya Tachibana; Linda Younkin; Aishe Kurti; Minerva M Carrasquillo; Fanggeng Zou; Daniel Sevlever; Gina Bisceglio; Ming Gan; Romain Fol; Patrick Knight; Miao Wang; Xianlin Han; John D Fryer; Michael L Fitzgerald; Yasumasa Ohyagi; Steven G Younkin; Guojun Bu; Takahisa Kanekiyo
Journal:  J Neurosci       Date:  2016-03-30       Impact factor: 6.167

10.  ATP-binding cassette transporter A7 (ABCA7) loss of function alters Alzheimer amyloid processing.

Authors:  Kanayo Satoh; Sumiko Abe-Dohmae; Shinji Yokoyama; Peter St George-Hyslop; Paul E Fraser
Journal:  J Biol Chem       Date:  2015-08-10       Impact factor: 5.157

View more
  7 in total

1.  Strategies to gain novel Alzheimer's disease diagnostics and therapeutics using modulators of ABCA transporters.

Authors:  Jens Pahnke; Pablo Bascuñana; Mirjam Brackhan; Katja Stefan; Vigneshwaran Namasivayam; Radosveta Koldamova; Jingyun Wu; Luisa Möhle; Sven Marcel Stefan
Journal:  Free Neuropathol       Date:  2021-12-13

Review 2.  The role of ATP-binding cassette subfamily A in the etiology of Alzheimer's disease.

Authors:  Liene Bossaerts; Rita Cacace; Christine Van Broeckhoven
Journal:  Mol Neurodegener       Date:  2022-04-27       Impact factor: 18.879

Review 3.  ABCA7 and Pathogenic Pathways of Alzheimer's Disease.

Authors:  Tomonori Aikawa; Marie-Louise Holm; Takahisa Kanekiyo
Journal:  Brain Sci       Date:  2018-02-05

Review 4.  Lipids and Alzheimer's Disease.

Authors:  Yu-Chia Kao; Pei-Chuan Ho; Yuan-Kun Tu; I-Ming Jou; Kuen-Jer Tsai
Journal:  Int J Mol Sci       Date:  2020-02-22       Impact factor: 5.923

5.  ABCA7 rs3764650 Polymorphism is Associated with Delayed Neurocognitive Recovery.

Authors:  Lu Yu; Haiyan Ji; Minmin Zhou; Yaxin Guo; Junfeng Liu; Daoyun Lei; Chao Han; Tieliang Ma
Journal:  Pharmgenomics Pers Med       Date:  2022-03-30

6.  Rare missense mutations in ABCA7 might increase Alzheimer's disease risk by plasma membrane exclusion.

Authors:  Liene Bossaerts; Elisabeth Hendrickx Van de Craen; Rita Cacace; Bob Asselbergh; Christine Van Broeckhoven
Journal:  Acta Neuropathol Commun       Date:  2022-03-31       Impact factor: 7.801

Review 7.  In vivo methods for acute modulation of gene expression in the central nervous system.

Authors:  Andrzej W Cwetsch; Bruno Pinto; Annalisa Savardi; Laura Cancedda
Journal:  Prog Neurobiol       Date:  2018-04-22       Impact factor: 11.685

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.